CT software MIM SurePlan™ LiverY90

PETSPECToncology

MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT. Use it alone, or integrate with the larger MIM ecosystem to take advantage of a comprehensive, vendor-neutral platform for Nuclear Medicine processing and review. Read with Confidence Now you can read PET/CT, PET/MR, SPECT/CT, and planar Nuclear Medicine images from any major manufacturer—all in one system. Treat with Confidence Limitations in knowledge and certainty often accompany subsequent Y90 treatments. Many oncologists have questions surrounding follow-up for dose delivery and coverage. MIM SurePlan LiverY90 can put an end to not knowing. Know Your Dose the Day of Treatment Patient-specific dosimetry overcomes the uncertainty that the existing planning methods do not correlate with the actual dose delivered Timesaving Tools MIM SurePlan LiverY90 is specifically engineered for Y90, making efficiency a top priority. A recent study1 in the Journal of Nuclear Medicine demonstrated a 70% reduction in time compared to manual outlining of the liver. Empower Your Oncologists With patient-specific dosimetry, referrers have increased confidence that Y90 is a more legitimate treatment option. Make the best treatment path available to your patient by opening up subsequent treatment options using the knowledge gained. Post-Op Dosimetry Calculate dose using Y90-PET and Bremsstrahlung SPECT. Calculate isodose curves/DVH on PET/SPECT using Local Disposition Method or MIRD Kernal. Flexible Workflows Quickly see and run pretreatment and posttreatment workflows from the sidebar